Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
The report details the trend, potential and market size of Blinatumomab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Blinatumomabmarket, defines the market attractiveness level of Blinatumomab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Blinatumomab industry, describes the types of Blinatumomab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blinatumomab market and the development prospects and opportunities of Blinatumomab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blinatumomab market in Chapter 13.
By Player:
Amgen
By Type:
Prefilled
Non-prefilled
By End-User:
Hospital
Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Blinatumomab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Blinatumomab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Blinatumomab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Blinatumomab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Blinatumomab Market Analysis and Outlook to 2022
-
7.1 Global Blinatumomab Consumption (2017-2022)
-
7.2 United States Blinatumomab Consumption (2017-2022)
-
7.3 Europe Blinatumomab Consumption (2017-2022)
-
7.4 China Blinatumomab Consumption (2017-2022)
-
7.5 Japan Blinatumomab Consumption (2017-2022)
-
7.6 India Blinatumomab Consumption (2017-2022)
-
7.7 South Korea Blinatumomab Consumption (2017-2022)
8 Region and Country-wise Blinatumomab Market Analysis and Outlook to 2028
-
8.1 Global Blinatumomab Consumption Forecast (2022-2028)
-
8.2 United States Blinatumomab Consumption Forecast (2022-2028)
-
8.3 Europe Blinatumomab Consumption Forecast (2022-2028)
-
8.4 China Blinatumomab Consumption Forecast (2022-2028)
-
8.5 Japan Blinatumomab Consumption Forecast (2022-2028)
-
8.6 India Blinatumomab Consumption Forecast (2022-2028)
-
8.7 South Korea Blinatumomab Consumption Forecast (2022-2028)
9 Global Blinatumomab Market Outlook by Types and Applications to 2022
-
9.1 Global Blinatumomab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prefilled Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-prefilled Consumption and Growth Rate (2017-2022)
-
9.2 Global Blinatumomab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Blinatumomab Market Outlook by Types and Applications to 2028
-
10.1 Global Blinatumomab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prefilled Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-prefilled Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Blinatumomab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Blinatumomab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Blinatumomab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Blinatumomab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Blinatumomab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Blinatumomab Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Blinatumomab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Blinatumomab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Blinatumomab
-
Figure Blinatumomab Picture
-
Table Global Blinatumomab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blinatumomab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blinatumomab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Blinatumomab Consumption by Country (2017-2022)
-
Figure United States Blinatumomab Consumption and Growth Rate (2017-2022)
-
Table Europe Blinatumomab Consumption and Growth Rate (2017-2022)
-
Figure China Blinatumomab Consumption and Growth Rate (2017-2022)
-
Figure Japan Blinatumomab Consumption and Growth Rate (2017-2022)
-
Figure India Blinatumomab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Blinatumomab Consumption and Growth Rate (2017-2022)
-
Figure Global Blinatumomab Consumption Forecast by Country (2022-2028)
-
Figure United States Blinatumomab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Blinatumomab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Blinatumomab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Blinatumomab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Blinatumomab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Blinatumomab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prefilled Consumption and Growth Rate (2017-2022)
-
Figure Global Non-prefilled Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Prefilled Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-prefilled Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Blinatumomab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Blinatumomab Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Blinatumomab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Blinatumomab Product and Service
-
